• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注射硬化疗法治疗食管静脉曲张病例的长期预后

Long-term prognosis of esophageal variceal cases treated with injection sclerotherapy.

作者信息

Miyoshi H, Tei H, Ashida K, Osaka N, Matsumoto A, Hirata I, Ohshiba S

机构信息

Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan.

出版信息

Gastroenterol Jpn. 1989 Oct;24(5):469-75. doi: 10.1007/BF02773871.

DOI:10.1007/BF02773871
PMID:2806827
Abstract

One hundred fifty-two patients with esophageal varices underwent a total of 485 injection sclerotherapy procedures (mean, 3.2 times per each case). During 5 years of observation, 20 cases (13.2%) died following injection sclerotherapy. The 3-year survival rates, based on the Kaplan-Meier method, were 42% for emergency cases, 75% for elective cases and 90% for prophylactic cases. Significant differences (P less than 0.05) by the generalized Wilcoxon test were observed in the survival rates between emergency cases and prophylactic cases, and also between elective cases and prophylactic cases. Two cases (8.6%) of failure to control acute hemostasis were experienced. Twenty cases of bleeding after sclerotherapy were experienced, and 8 died of bleeding. The three-year bleeding rate according to the Kaplan-Meier method was 59% for emergency cases, 25% for elective cases and 7% for prophylactic cases. A significant difference (P less than 0.05) by the generalized Wilcoxon test was observed in the bleeding rate between elective cases and prophylactic cases. Non-bleeding rate (100%-bleeding rate) after sclerotherapy showed almost the same values as the survival rate. These results indicate that upper digestive tract hemorrhage influences the prognosis of patients after sclerotherapy.

摘要

152例食管静脉曲张患者共接受了485次注射硬化治疗(平均每例3.2次)。在5年的观察期内,20例(13.2%)患者在注射硬化治疗后死亡。根据Kaplan-Meier法,急诊病例的3年生存率为42%,择期病例为75%,预防性病例为90%。广义Wilcoxon检验显示,急诊病例与预防性病例之间以及择期病例与预防性病例之间的生存率存在显著差异(P<0.05)。有2例(8.6%)未能控制急性出血。硬化治疗后有20例发生出血,其中8例死于出血。根据Kaplan-Meier法,急诊病例的3年出血率为59%,择期病例为25%,预防性病例为7%。广义Wilcoxon检验显示,择期病例与预防性病例之间的出血率存在显著差异(P<0.05)。硬化治疗后的无出血率(100% - 出血率)与生存率几乎相同。这些结果表明,上消化道出血影响硬化治疗后患者的预后。

相似文献

1
Long-term prognosis of esophageal variceal cases treated with injection sclerotherapy.注射硬化疗法治疗食管静脉曲张病例的长期预后
Gastroenterol Jpn. 1989 Oct;24(5):469-75. doi: 10.1007/BF02773871.
2
A prognostic evaluation of endoscopic intravariceal injection sclerotherapy for esophageal varices.内镜下食管静脉曲张硬化剂注射治疗的预后评估
Gastroenterol Jpn. 1989 Aug;24(4):347-56. doi: 10.1007/BF02774339.
3
Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients.内镜注射硬化治疗后静脉曲张再出血及复发:对204例患者的前瞻性评估
Arch Surg. 2000 Nov;135(11):1315-22. doi: 10.1001/archsurg.135.11.1315.
4
Endoscopic injection sclerotherapy for esophageal varices in cirrhotic patients without hepatocellular carcinoma: a comparison of longterm survival between prophylactic therapy and emergency therapy.
J Gastroenterol. 2003;38(4):361-4. doi: 10.1007/s005350300064.
5
Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience.胃静脉曲张硬化疗法的长期随访:十一年经验
Gastrointest Endosc. 1997 Jul;46(1):8-14. doi: 10.1016/s0016-5107(97)70202-5.
6
Sclerotherapy on liver cirrhosis with esophageal variceal bleeding: eight years of experience.肝硬化合并食管静脉曲张出血的硬化疗法:八年经验
Zhonghua Yi Xue Za Zhi (Taipei). 1994 Nov;54(5):321-8.
7
Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk.食管横断术与注射硬化疗法治疗高危患者食管静脉曲张出血的比较
Surg Gynecol Obstet. 1985 Jun;160(6):539-46.
8
Endoscopic hemostasis for bleeding gastric varices treated by combination of variceal ligation and sclerotherapy with N-butyl-2-cyanoacrylate.内镜下使用套扎术联合聚桂醇硬化剂注射及氰基丙烯酸正丁酯治疗胃静脉曲张出血的止血治疗
J Gastroenterol. 2007 Jul;42(7):528-32. doi: 10.1007/s00535-007-2041-0. Epub 2007 Jul 25.
9
Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: a nine-year prospective study.1000例食管静脉曲张患者的内镜注射硬化疗法:一项为期九年的前瞻性研究。
Hepatology. 1992 Jan;15(1):69-75. doi: 10.1002/hep.1840150114.
10
Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation.内镜治疗后食管静脉曲张复发及其对再出血的影响:硬化疗法与结扎术的比较
J Hepatol. 2000 Feb;32(2):202-8. doi: 10.1016/s0168-8278(00)80064-1.

本文引用的文献

1
The general rules for recording endoscopic findings on esophageal varices.记录食管静脉曲张内镜检查结果的一般规则。
Jpn J Surg. 1980 Mar;10(1):84-7. doi: 10.1007/BF02468653.
2
Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.内镜下对食管壁静脉曲张进行预防性硬化治疗——一项前瞻性对照随机试验。
Endoscopy. 1982 Jan;14(1):4-5. doi: 10.1055/s-2007-1021560.
3
Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery.对接受急诊和择期手术的患者进行食管静脉曲张硬化剂注射治疗。
Surgery. 1982 Sep;92(3):474-9.
4
Prediction of variceal hemorrhage by esophageal endoscopy.通过食管内镜检查预测静脉曲张出血
Gastrointest Endosc. 1981 Nov;27(4):213-8. doi: 10.1016/s0016-5107(81)73224-3.
5
Sclerotherapy of esophageal varices--Argentinian experience.
Endoscopy. 1983 May;15 Suppl 1:141-3. doi: 10.1055/s-2007-1021489.
6
Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial.反复注射硬化疗法未能改善食管静脉曲张出血后的长期生存率。一项为期五年的前瞻性对照临床试验。
Lancet. 1983 Dec 10;2(8363):1328-32. doi: 10.1016/s0140-6736(83)91090-5.
7
Transection of the oesophagus for bleeding oesophageal varices.为治疗食管静脉曲张出血而行食管横断术。
Br J Surg. 1973 Aug;60(8):646-9. doi: 10.1002/bjs.1800600817.
8
Long-term sclerotherapy of bleeding esophageal varices in patients with liver cirrhosis. An evaluation of mortality and rebleeding risk factors.肝硬化患者食管静脉曲张出血的长期硬化疗法。死亡率及再出血危险因素评估。
Scand J Gastroenterol. 1985 Jan;20(1):51-8. doi: 10.3109/00365528509089632.
9
Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after the introduction of sclerotherapy: a retrospective analysis.
Mayo Clin Proc. 1985 Mar;60(3):149-57. doi: 10.1016/s0025-6196(12)60211-0.
10
Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial.注射硬化疗法治疗食管静脉曲张后生存率的提高:一项对照试验的最终分析
Hepatology. 1985 Sep-Oct;5(5):827-30. doi: 10.1002/hep.1840050520.